-
Nanoparticle anti-cancer vaccine shown to be effective against triple negative breast cancer, pancreatic cancer, and melanoma in mouse model study.
Medical Mythbusting Commentary for October 28, 2025 Source:This experimental “super vaccine” stopped cancer cold in the lab Reference:Super-adjuvant nanoparticles for platform cancer vaccination
-
mRNA-derived pancreatic cancer vaccine demonstrates efficacy in small study. Much more evaluation required for these bespoke vaccines.
Medical Mythbusting Commentary for March 17, 2025 Source:Pancreatic cancer vaccine shows hope. Make the investment. Reference:RNA vaccine induces long-lived anti-tumour T cells in pancreatic cancer
-
mRNA vaccines show promise in pancreatic cancer in early trial
Medical Mythbusting Commentary for February 21, 2025 Source:mRNA vaccines show promise in pancreatic cancer in early trial Reference:RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer
-
Pancreatic Cancer Vaccine Shows Promise in Small Trial
Medical Mythbusting Commentary for May 11, 2023 Source:Pancreatic Cancer Vaccine Shows Promise in Small Trial Reference:Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer
-
Discovery of largely unchanged ‘weak spot’ in COVID-19 variants could lead to better treatment options
Medical Mythbusting Commentary for August 19, 2022 Source:Discovery of ‘weak spot’ in COVID-19 variants could lead to better treatment options Reference:SARS-CoV-2 variants of concern: spike protein mutational analysis and epitope for broad neutralization
-
A vaccine for Lyme disease is in its Phase 3 trial. Results to date show efficacy and safety. If trial is successful, official authorization expected in 2025.
Medical Mythbusting Commentary for August 10, 2022 Source:A vaccine for Lyme disease is in its final clinical trial
-
Moderna releases data on Omicron version of their vaccine.
Medical Mythbusting Commentary for June 9, 2022 Source:Moderna says experimental combination COVID-19 vaccine appears to work against Omicron
-
New Type Of Cancer Vaccine Bypasses Tumor Defenses In Animal Studies
Medical Mythbusting Commentary for May 30, 2022 Source:New Type Of Cancer Vaccine Bypasses Tumor Defenses In Animal Studies Reference:A vaccine targeting resistant tumours by dual Tcell plus NK cell attack
-
Pfizer applies to FDA for approval of three-dose pediatric COVID-19 vaccine for children under five years of age.
Medical Mythbusting Commentary for May 25, 2022 Source:Pfizer says 3 COVID-19 shots protect children under 5